#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Chorioretinitis Dedifferentiated liposarcoma Infantile spasms Immune-mediated enterocolitis Autoimmune disorder Deafness neurosensory Diffuse large B-cell lymphoma refractory Mantle cell lymphoma stage III Nephropathy Endometrial cancer recurrent Myxofibrosarcoma Germ cell cancer Progressive supranuclear palsy Leukocyte adhesion deficiency Neuroblastoma More trials…

Learn about Rare Diseases

Angelman’s syndrome – Basic Information Acquired haemophilia – Diagnostics MELAS syndrome – Trials in Disease Mantle cell lymphoma stage IV – Trials in Disease Alternating hemiplegia of childhood – Diagnostics Alport’s syndrome – Treatment Sarcoidosis – Life with Disease Haemolytic uraemic syndrome – Basic Information Hepatic angiosarcoma – Life with Disease Haemophagocytic lymphohistiocytosis – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Gadoquatrane Hydrocortisone Acetate MAPLIRPACEPT BMS-986470 Cetrorelix Fezolinetant Alnuctamab Cldn6 Rna-Lpx Sodium Sulfate Anhydrous Mesenchymal Cells Ublituximab Evg321 Emactuzumab Darolutamide Baricitinib Anhydrous Docetaxel Ly3298176 Moxifloxacin Hydrochloride Gadoxetic Acid, Disodium BUDOPRUTUG More therapies…

Learn about Your Condition

Epiphysiolysis Cutibacterium acnes infection Anorexia nervosa Vascular dementia Appendicitis Mesothelioma malignant Alexander disease Bronchostenosis Angiosarcoma metastatic Osteotomy Transitional cell carcinoma Endometrial cancer stage II Malignant melanoma Epilepsy Obsessive-compulsive disorder More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Hormone receptor positive HER2 negative breast cancer

Study on the Effect of Tamoxifen and Chemotherapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer with Low Recurrence Scores

Not recruiting

3 1 1 1
Investigated Diseases:
- HER2 negative breast cancer
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- ZELENECTIDE PEVEDOTIN

1 … 9 10 11

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Hormone receptor positive HER2 negative breast cancer

Study on the Effect of Tamoxifen and Chemotherapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer with Low Recurrence Scores

Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies